Stories about Chemie
- 3One documentmore
Press release: STADA continues with double-digit sales and profit growth in 2023
One documentmore- 5
Press Release - Performance at the Highest Level: the new NewV set UEL 5000
One documentmore - 8
Current market study forecasts annual growth of 17 % for bio-based polymers between 2023 and 2028. Demand from Asia and the USA in particular is driving growth, Europe is lagging behind.
2 Documentsmore LTS Lohmann Therapie-Systeme AG
First product based on LTS’ Sorrel(TM) wearable drug delivery platform launched in the US
more- 5
Bio-based innovations for industrial applications: stakeholder event
One documentmore LAMILUX Academy webinars enter a new round
One documentmore- 3
Navigating a Renewable Carbon Future with the Program of the CO₂-Based Fuels and Chemicals Conference 2024
One documentmore The ocean – a climate champion? How to boost marine carbon dioxide uptake
more- 7
Press Release - hubergroup Chemicals presents its portfolio at PaintIndia
One documentmore - 3
Press Release - Management change at the top of the hubergroup
One documentmore Press release: STADA and Alvotech secure approval for Uzpruvo, Europe’s first ustekinumab biosimilar to Stelara
STADA and Alvotech secure approval for Uzpruvo, Europe’s first ustekinumab biosimilar to Stelara - Marketing authorization issued in European Economic Area for Uzpruvo®, the first biosimilar to Stelara®, a biologic therapy within ...
One documentmorePress release: Zuellig Pharma becomes STADA Philippines’ exclusive distribution partner
One documentmoreAcousia Therapeutics attracts new investor on its path to make hearing loss a treatable disease
Tübingen (ots) - - German pioneer biotech accelerates hearing loss solution development with fresh capital boost Acousia Therapeutics GmbH, a clinical-stage biotech company developing drug candidates against acute and chronic forms of hearing loss, proudly announces Esperante Ventures as the latest addition to its esteemed group of investors. The infusion of fresh ...
moreBiesterfeld and Celanese: global expansion and enhanced joint portfolio as of 2024
Hamburg (ots) - International distributor Biesterfeld and leading technical plastics manufacturer Celanese are further expanding their collaboration in the new year. The partners have agreed to enhance their joint portfolio and to cooperate to develop new markets. Extended distribution rights in the EMEA region Biesterfeld will continue to hold exclusive distribution ...
moreLTS Lohmann Therapie-Systeme AG
LTS receives $4.3 Million grant for the development of contraceptive Microneedle Array Patches
more- 2
Towards Advanced CO₂ Utilisation and a Defossilisation of The Chemical Industry
One documentmore EUBP unveils the results of the 2023 Market Data Report
Berlin (ots) - European Bioplastics unveils the 2023 edition of the market development update during EBC23 taking place in Berlin, Germany. Main findings show that after a period of stagnation, the overall plastic production is picking up again. The global production for bioplastics is taking off after a few years of stagnation, induced by Covid-19 mainly. This development is driven by rising demand combined with the ...
moreLTS Lohmann Therapie-Systeme AG
LTS receives grant of $1.2 Million to support the development of thermostable mRNA formulations for Microneedle Array Patches
more- 8
The Advanced Recycling Conference 2023 – A Success Story Beyond Chemical Recycling
One documentmore European Parliament sends mixed signals to the bioplastics sector
moreTakeda Pharma Vertrieb GmbH & Co. KG
The European Commission Approves Label Update for TAKHZYRO® (lanadelumab), Expanding Its Use to a Broader Group of Paediatric Patients with Recurrent Attacks of Hereditary Angioedema (HAE)
Zurich (ots/PRNewswire) - - TAKHZYRO® is the First Routine Prevention Treatment of HAE Approved in the EU for Patients Under the Age of Six. - The therapeutical indication for TAKHZYRO® has been extended to patients aged 2 years and older.1 - Offers a New Preventative Treatment Option for young HAE patients with ...
moreBiomay Announces Expansion of GMP-Facilities to Offer mRNA Manufacturing and Aseptic Filling Services
moreIpsen and Medison Pharma Announce Health Canada Approval of Bylvay™ (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC)
Zug, Switzerland and Paris (ots/PRNewswire) - Bylvay (odevixibat) is the first and only oral treatment available in Canada for the treatment of pruritus due to this rare genetic condition Today, Ipsen (Euronext: IPN) (ADR: IPSEY), a global biopharmaceutical company focused on transformative medicines in oncology, ...
moreSoterios Pharma completes Phase II enrolment for STS-01 in mild / moderate (patchy) alopecia areata
London (ots/PRNewswire) - Soterios Pharma, a privately held clinical-stage pharmaceutical company, announced today that it has completed target enrolment for its Phase II trial with STS-01 for mild / moderate (patchy) alopecia areata. Final results of the study are anticipated to be available in Q2 2024. David Fleet, CEO of Soterios Pharma, said, "This represents an ...
moreTechnische Universität München
Start-up dedicated to developing new antibiotics
TECHNICAL UNIVERSITY OF MUNICH NEWS RELEASE Smartbax nominated for Falling Walls award Start-up dedicated to developing new antibiotics • New approach against resistant pathogens • Agent damages protein transport and energy balance of bacteria • Two TUM spin-offs nominated for Science Breakthrough of the Year at Falling Walls Summit It all began with basic research: While conducting laboratory experiments, a team ...
more#Greentech: MECAWARE secures €40m to become the leader in battery recycling and the production of strategic metals in France and Europe
Lyon, France (ots/PRNewswire) - In order to speed up its industrial and commercial development, MECAWARE has secured €40 million from a pool of investors, the French government, under the auspices of the France 2030 plan, and its banking partners. This funding will enable the industrialisation of the pilot scheme ...
more- 4
Catalysing Change – Smart CO₂-Solutions Wanted for the “Best CO₂ Utilisation 2024” Innovation Award
One documentmore Gerresheimer at CPHI: focus on high-value solutions and sustainability
Duesseldorf (ots) - - Gerresheimer presents an extensive portfolio of containment solutions, drug delivery systems and digital therapy support - High-quality ready-to-fill solutions for biopharmaceuticals, cell and gene therapy - EcoDesign and environmentally friendly packaging options ensure greater sustainability Gerresheimer, an innovative system and solution ...
more- 5
Be Part of the Chemistry and Materials Industry's Transition From Fossil to Renewable Carbon!
One documentmore